SUPN logo

Supernus Pharmaceuticals, Inc. (SUPN) Operating profit

annual operating profit:

$75.56M+$62.15M(+463.72%)
December 31, 2024

Summary

  • As of today (September 16, 2025), SUPN annual operating income is $75.56 million, with the most recent change of +$62.15 million (+463.72%) on December 31, 2024.
  • During the last 3 years, SUPN annual operating profit has fallen by -$3.94 million (-4.96%).
  • SUPN annual operating profit is now -56.97% below its all-time high of $175.60 million, reached on December 31, 2020.

Performance

SUPN Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

quarterly operating profit:

$11.14M+$13.74M(+529.16%)
June 30, 2025

Summary

  • As of today (September 16, 2025), SUPN quarterly operating income is $11.14 million, with the most recent change of +$13.74 million (+529.16%) on June 30, 2025.
  • Over the past year, SUPN quarterly operating profit has dropped by -$7.07 million (-38.83%).
  • SUPN quarterly operating profit is now -80.15% below its all-time high of $56.14 million, reached on September 30, 2020.

Performance

SUPN quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

TTM operating profit:

$67.94M-$7.07M(-9.43%)
June 30, 2025

Summary

  • As of today (September 16, 2025), SUPN TTM operating income is $67.94 million, with the most recent change of -$7.07 million (-9.43%) on June 30, 2025.
  • Over the past year, SUPN TTM operating profit has increased by +$27.30 million (+67.18%).
  • SUPN TTM operating profit is now -62.90% below its all-time high of $183.12 million, reached on March 31, 2021.

Performance

SUPN TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

SUPN Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+463.7%-38.8%+67.2%
3 y3 years-5.0%-7.8%+0.3%
5 y5 years-49.1%-79.0%-58.2%

SUPN Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-5.0%+463.7%-72.0%+166.3%-9.4%+1107.5%
5 y5-year-57.0%+463.7%-80.2%+166.3%-62.9%+1107.5%
alltimeall time-57.0%+222.0%-80.2%+157.5%-62.9%+207.3%

SUPN Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$11.14M(-529.2%)
$67.94M(-9.4%)
Mar 2025
-
-$2.60M(-113.3%)
$75.01M(+2.3%)
Dec 2024
$75.56M(+463.7%)
$19.56M(-50.9%)
$73.36M(+0.8%)
Sep 2024
-
$39.83M(+118.7%)
$72.78M(+79.1%)
Jun 2024
-
$18.21M(-528.8%)
$40.64M(+622.3%)
Mar 2024
-
-$4.25M(-122.4%)
$5.63M(-58.0%)
Dec 2023
$13.40M(-70.6%)
$18.99M(+147.2%)
$13.40M(-49.1%)
Sep 2023
-
$7.68M(-145.7%)
$26.34M(+49.5%)
Jun 2023
-
-$16.80M(-576.0%)
$17.63M(-62.1%)
Mar 2023
-
$3.53M(-88.9%)
$46.51M(+2.0%)
Dec 2022
$45.61M(-42.6%)
$31.93M(-3179.1%)
$45.61M(+46.2%)
Sep 2022
-
-$1.04M(-108.6%)
$31.20M(-53.9%)
Jun 2022
-
$12.09M(+359.3%)
$67.72M(-9.2%)
Mar 2022
-
$2.63M(-85.0%)
$74.60M(-26.3%)
Dec 2021
$79.50M(-54.7%)
$17.52M(-50.6%)
$101.20M(-21.2%)
Sep 2021
-
$35.48M(+87.1%)
$128.48M(-13.9%)
Jun 2021
-
$18.96M(-35.1%)
$149.13M(-18.6%)
Mar 2021
-
$29.23M(-34.7%)
$183.12M(+0.1%)
Dec 2020
$175.60M(+18.2%)
$44.80M(-20.2%)
$182.90M(+2.2%)
Sep 2020
-
$56.14M(+6.0%)
$178.92M(+10.1%)
Jun 2020
-
$52.95M(+82.5%)
$162.50M(+6.8%)
Mar 2020
-
$29.01M(-28.9%)
$152.16M(+2.4%)
Dec 2019
$148.57M(+2.9%)
$40.82M(+2.7%)
$148.57M(+0.7%)
Sep 2019
-
$39.73M(-6.7%)
$147.61M(+1.6%)
Jun 2019
-
$42.60M(+67.5%)
$145.36M(+5.0%)
Mar 2019
-
$25.43M(-36.2%)
$138.48M(-4.1%)
Dec 2018
$144.44M(+45.1%)
$39.85M(+6.4%)
$144.44M(+4.0%)
Sep 2018
-
$37.48M(+4.9%)
$138.93M(+12.2%)
Jun 2018
-
$35.72M(+13.8%)
$123.80M(+8.5%)
Mar 2018
-
$31.39M(-8.6%)
$114.15M(+14.7%)
Dec 2017
$99.54M
$34.34M(+53.7%)
$99.54M(+22.1%)
DateAnnualQuarterlyTTM
Sep 2017
-
$22.34M(-14.3%)
$81.49M(+3.2%)
Jun 2017
-
$26.07M(+55.3%)
$78.99M(+22.3%)
Mar 2017
-
$16.79M(+3.0%)
$64.57M(+19.1%)
Dec 2016
$54.22M(+160.1%)
$16.30M(-17.9%)
$54.22M(+18.4%)
Sep 2016
-
$19.84M(+70.4%)
$45.80M(+51.3%)
Jun 2016
-
$11.64M(+80.9%)
$30.27M(+34.7%)
Mar 2016
-
$6.44M(-18.3%)
$22.47M(+12.0%)
Dec 2015
$20.84M(-494.9%)
$7.88M(+82.9%)
$20.07M(+18.6%)
Sep 2015
-
$4.31M(+12.1%)
$16.92M(-59.5%)
Jun 2015
-
$3.84M(-4.7%)
$41.77M(+0.2%)
Mar 2015
-
$4.03M(-14.7%)
$41.69M(+72.0%)
Dec 2014
-$5.28M(-91.5%)
$4.73M(-83.8%)
$24.23M(+197.5%)
Sep 2014
-
$29.17M(+676.5%)
$8.14M(-121.3%)
Jun 2014
-
$3.76M(-128.0%)
-$38.20M(-33.5%)
Mar 2014
-
-$13.42M(+18.2%)
-$57.43M(-7.2%)
Dec 2013
-$61.92M(+46.8%)
-$11.36M(-33.9%)
-$61.92M(-2.2%)
Sep 2013
-
-$17.18M(+11.0%)
-$63.30M(+8.4%)
Jun 2013
-
-$15.48M(-13.6%)
-$58.42M(+11.9%)
Mar 2013
-
-$17.91M(+40.5%)
-$52.20M(+23.8%)
Dec 2012
-$42.17M(+11.7%)
-$12.74M(+3.7%)
-$42.17M(+6.3%)
Sep 2012
-
-$12.29M(+32.8%)
-$39.67M(+6.4%)
Jun 2012
-
-$9.26M(+17.5%)
-$37.29M(+2.4%)
Mar 2012
-
-$7.88M(-23.1%)
-$36.43M(-3.5%)
Dec 2011
-$37.75M(-5.9%)
-$10.24M(+3.3%)
-$37.75M(-19.5%)
Sep 2011
-
-$9.91M(+18.1%)
-$46.90M(+26.8%)
Jun 2011
-
-$8.40M(-8.7%)
-$36.98M(+29.4%)
Mar 2011
-
-$9.20M(-52.6%)
-$28.59M(+47.4%)
Dec 2010
-$40.12M(-1099.1%)
-$19.39M(+41.1%)
-$19.39M(+41.1%)
Dec 2009
$4.02M(-115.5%)
-$13.74M
-$13.74M
Dec 2008
-$25.86M(+35.8%)
-
-
Dec 2007
-$19.05M
-
-

FAQ

  • What is Supernus Pharmaceuticals, Inc. annual operating income?
  • What is the all time high annual operating profit for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. annual operating profit year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. quarterly operating income?
  • What is the all time high quarterly operating profit for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. TTM operating income?
  • What is the all time high TTM operating profit for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. TTM operating profit year-on-year change?

What is Supernus Pharmaceuticals, Inc. annual operating income?

The current annual operating profit of SUPN is $75.56M

What is the all time high annual operating profit for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high annual operating income is $175.60M

What is Supernus Pharmaceuticals, Inc. annual operating profit year-on-year change?

Over the past year, SUPN annual operating income has changed by +$62.15M (+463.72%)

What is Supernus Pharmaceuticals, Inc. quarterly operating income?

The current quarterly operating profit of SUPN is $11.14M

What is the all time high quarterly operating profit for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high quarterly operating income is $56.14M

What is Supernus Pharmaceuticals, Inc. quarterly operating profit year-on-year change?

Over the past year, SUPN quarterly operating income has changed by -$7.07M (-38.83%)

What is Supernus Pharmaceuticals, Inc. TTM operating income?

The current TTM operating profit of SUPN is $67.94M

What is the all time high TTM operating profit for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high TTM operating income is $183.12M

What is Supernus Pharmaceuticals, Inc. TTM operating profit year-on-year change?

Over the past year, SUPN TTM operating income has changed by +$27.30M (+67.18%)
On this page